“…Six ASLs were synthesized with various substitutions at the position of U 33 (Fig+ 2)+ Each substitution was designed to test the functional importance of one or more of the interactions contributed by U 33 to the U-turn structure (Table 1)+ Two of the ASLs were designed such that nucleoside-33 lacked the ability to donate a proton from the 29-OH: 29-O-methyluridine (ASL-Um 33 ) and 29-deoxyuridine (ASL-dU 33 )+ Others were designed to negate proton donation from the N 3 -H position: cytidine (ASL-C 33 ), N 3 -methyluridine (ASL-m 3 U 33 ), and 6-methyluridine (ASL-m 6 U 33 )+ The latter precludes proton donation from N 3 to the phosphate of A 36 because the N-glycosidic bond of m 6 U 33 takes the syn conformation both in the mononucleoside (Felczak et al+, 1996) and within the ASL+ The syn, C39-endo conformation of m 6 U 33 in the ASL was determined by NMR spectroscopy (R+ Cain and P+F+ Agris, pers+ comm+)+ Two ASLs were designed to force the dynamic U 33 sugar pucker (;50% C39 endo in solution) to either the C39-endo conformation by methylation (ASL-Um 33 ; Kawai et al+, 1992) or the C29-endo conformation by elimination (ASLdU 33 ; Basti et al+, 1996)+ An additional ASL containing dihydrouridine (ASL-D 33 ) was designed to have the C29-endo sugar pucker, but unlike ASL-dU 33 , would retain the ability to donate a proton from the 29-OH+ Dihydrouridine is known to be highly constrained to the C29-endo conformation as a mononucleoside (Sundaralingam et al+, 1971) and within tRNAs and oligomers (Dalluge et al+, 1996(Dalluge et al+, , 1997Stuart et al+, 1996)+ Particular nucleoside substitutions, such as m 6 U 33 and D 33 , were also designed to affect the stacking interactions that characterize position 33+ The syn conformation of m 6 U 33 and the nonplanar, nonaromatic character of D 33 would negatively affect stacking interactions+ Thus, nucleosides substituted for U 33 were chosen for their abilities to disrupt local noncanonical H-bonds in the loop or affect nucleoside conformation and stacking interactions+ These substitutions could, however, have affected structure beyond that of the anticodon loop and would, in turn, affect the assessment of ribosome binding+…”